241 related articles for article (PubMed ID: 9268048)
41. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
42. The Reproductive Effects Assessment Group's report on the mutagenicity of 1,3-butadiene and its reactive metabolites.
Rosenthal SL
Environ Mutagen; 1985; 7(6):933-45. PubMed ID: 2933247
[TBL] [Abstract][Full Text] [Related]
43. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
[TBL] [Abstract][Full Text] [Related]
44. Investigation on the mechanisms of genotoxicity of butadiene, styrene and their combination in human lymphocytes using the Comet assay.
Cemeli E; Mirkova E; Chiuchiarelli G; Alexandrova E; Anderson D
Mutat Res; 2009 May; 664(1-2):69-76. PubMed ID: 19428383
[TBL] [Abstract][Full Text] [Related]
45. Toxicity of 1,3-butadiene to bone marrow mimics haematopoietic defects observed in mice bearing white spotted or steel mutations.
Irons RD; Colagiovanni DB; Stillman WS
IARC Sci Publ; 1993; (127):205-15. PubMed ID: 7520886
[TBL] [Abstract][Full Text] [Related]
46. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
47. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
48. Effect of 4-vinylcyclohexene on micronucleus formation in the bone marrow of rats and mice.
Bevan C; Keller DA; Panepinto AS; Bentley KS
Drug Chem Toxicol; 2001 Aug; 24(3):273-85. PubMed ID: 11452399
[TBL] [Abstract][Full Text] [Related]
49. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
50. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
Cochrane JE; Skopek TR
Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
[TBL] [Abstract][Full Text] [Related]
51. Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites.
Kligerman AD; Hu Y
Chem Biol Interact; 2007 Mar; 166(1-3):132-9. PubMed ID: 16698003
[TBL] [Abstract][Full Text] [Related]
52. Induction of micronuclei and sister chromatid exchange in mouse splenocytes after exposure to the butadiene metabolite 3,4-epoxy-1-butene.
Stephanou G; Andrianopoulos C; Vlastos D; Demopoulos NA; Russo A
Mutagenesis; 1997 Nov; 12(6):425-9. PubMed ID: 9412995
[TBL] [Abstract][Full Text] [Related]
53. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene.
Osterman-Golkar SM; Bond JA; Ward JB; Legator MS
IARC Sci Publ; 1993; (127):127-34. PubMed ID: 8070858
[TBL] [Abstract][Full Text] [Related]
54. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
55. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
56. Comparison of induction of hprt mutations by 1,3-butadiene and/or its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo.
Tates AD; van Dam FJ; van Teylingen CM; de Zwart FA; Zwinderman AH
Mutat Res; 1998 Jan; 397(1):21-36. PubMed ID: 9463549
[TBL] [Abstract][Full Text] [Related]
57. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
[TBL] [Abstract][Full Text] [Related]
58. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
59. 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in vitro.
Sasiadek M; Norppa H; Sorsa M
Mutat Res; 1991 Oct; 261(2):117-21. PubMed ID: 1922154
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the genotoxic potential of 3-monochloropropane-1,2-diol (3-MCPD) and its metabolites, glycidol and beta-chlorolactic acid, using the single cell gel/comet assay.
El Ramy R; Ould Elhkim M; Lezmi S; Poul JM
Food Chem Toxicol; 2007 Jan; 45(1):41-8. PubMed ID: 16971032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
